- Who dares stay in hepatitis C as another drug dies?
- NICE recommends hep C drugs Olysio and Sovaldi
- Reading between the lines of J&J's $1.75bn Alios buy
- BMS's daclatasvir is first in class to garner CHMP nod
COMMENT Other Informa Comment
- PROFILE: Tuomo Pätsi describes Celgene's evolution and the emotional fallout of M&A
- INTERVIEW: Merck Serono's Belén Garijo on pricing, emerging markets and diversity